• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Patatin-like phospholipase domain-containing protein 4 (PNPLA4)

ACP00253

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP00253 Target NamePNPLA4
Target SynonymsCalcium-independent phospholipase A2-eta;iPLA2-eta;EC 3.1.1.4;Protein GS2FormLiquid or Lyophilized powder
Expression SystemE.coliExpression Range1-253aa
Mol Weight29.1 kDaProtein LengthFull length
PurityGreater than 90% as determined by SDS-PAGE.Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDP41247
Background Information
  • Uniprot Id

    P41247

  • Target Species

    Human

  • Target Name

    PNPLA4

  • Target Full Name

    Patatin-like phospholipase domain-containing protein 4

  • Target Function

    Has abundant triacylglycerol lipase activity. Transfers fatty acid from triglyceride to retinol, hydrolyzes retinylesters, and generates 1,3-diacylglycerol from triglycerides.

  • Target Involvement

    Defects in PNPLA4 may play a role in mitochondrial disorders characterized by complex IV deficiency.

  • Target Subcellular Location

    Mitochondrion.

  • Target Tissue Specificity

    Expressed in all tissues examined, including heart, brain, placenta, lung, liver, muscle, kidney, pancreas and spleen.

  • Target Research Area

    Cardiovascular

  • Target Synonyms

    Calcium independent phospholipases A2 eta; DXS1283E; GS2; IPLA2 eta; Patatin-like phospholipase domain-containing protein 4; PLPL4_HUMAN; PNPLA4; Protein GS2

Inquire Recombinant Human Patatin-like phospholipase domain-containing protein 4 (PNPLA4) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification